ES2478565T3 - Composiciones y sus usos - Google Patents

Composiciones y sus usos Download PDF

Info

Publication number
ES2478565T3
ES2478565T3 ES04798407.5T ES04798407T ES2478565T3 ES 2478565 T3 ES2478565 T3 ES 2478565T3 ES 04798407 T ES04798407 T ES 04798407T ES 2478565 T3 ES2478565 T3 ES 2478565T3
Authority
ES
Spain
Prior art keywords
starch
compositions
therapeutic food
hypoglycemia
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES04798407.5T
Other languages
English (en)
Other versions
ES2478565T5 (es
Inventor
Xin Qi
Richard Tester
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glycologic Ltd
Original Assignee
Glycologic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29726075&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2478565(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glycologic Ltd filed Critical Glycologic Ltd
Publication of ES2478565T3 publication Critical patent/ES2478565T3/es
Application granted granted Critical
Publication of ES2478565T5 publication Critical patent/ES2478565T5/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/212—Starch; Modified starch; Starch derivatives, e.g. esters or ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

El uso de un almidón en la preparación de una composici6n de alimento terapeutico o producto alimenticio terapeutico para el tratamiento o prevención de hipoglucemia en un individuo, en el que dicho almidón es almidón tratado con calor y humedad.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11

Claims (1)

  1. imagen1
ES04798407.5T 2003-11-06 2004-11-08 Composiciones y sus usos Active ES2478565T5 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0325942 2003-11-06
GBGB0325942.1A GB0325942D0 (en) 2003-11-06 2003-11-06 Compositions and uses thereof
PCT/GB2004/004682 WO2005044284A1 (en) 2003-11-06 2004-11-08 Compositions and uses therof

Publications (2)

Publication Number Publication Date
ES2478565T3 true ES2478565T3 (es) 2014-07-22
ES2478565T5 ES2478565T5 (es) 2018-04-17

Family

ID=29726075

Family Applications (1)

Application Number Title Priority Date Filing Date
ES04798407.5T Active ES2478565T5 (es) 2003-11-06 2004-11-08 Composiciones y sus usos

Country Status (17)

Country Link
US (1) US8507462B2 (es)
EP (1) EP1680134B2 (es)
JP (1) JP5248776B2 (es)
CN (1) CN1901922B (es)
AU (1) AU2004287263B2 (es)
CA (1) CA2544965C (es)
CY (1) CY1115306T1 (es)
DK (1) DK1680134T4 (es)
ES (1) ES2478565T5 (es)
GB (1) GB0325942D0 (es)
HK (1) HK1097754A1 (es)
HR (1) HRP20140660T4 (es)
NZ (1) NZ546987A (es)
PL (1) PL1680134T5 (es)
PT (1) PT1680134E (es)
SI (1) SI1680134T2 (es)
WO (1) WO2005044284A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0325942D0 (en) † 2003-11-06 2003-12-10 Glycologic Ltd Compositions and uses thereof
US8557274B2 (en) 2005-12-06 2013-10-15 Purdue Research Foundation Slowly digesting starch and fermentable fiber
WO2010077635A2 (en) * 2008-12-09 2010-07-08 The Ucan Company Heat moisture treated carbohydrates and uses thereof
US9481777B2 (en) 2012-03-30 2016-11-01 The Procter & Gamble Company Method of dewatering in a continuous high internal phase emulsion foam forming process

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1306384A (es) * 1969-05-05 1973-02-07
GB2026837A (en) * 1978-07-31 1980-02-13 Cpc International Inc Starch containing food products
AU5817590A (en) † 1989-06-06 1991-01-07 Washington State University Research Foundation, Inc. Purified resistant starch products and their preparation
JP2996707B2 (ja) * 1990-09-21 2000-01-11 三和興産株式会社 湿熱処理澱粉の効率的製造法
JPH06169680A (ja) * 1992-12-09 1994-06-21 Sanwa Kosan Kk パン類およびパン粉の製造法
IL112967A0 (en) † 1994-03-15 1995-06-29 Los Angeles Childrens Hospital Pharmaceutical compositions comprising a complex carbohydrate to diminish hypoglycemia in patients with diabetes mellitus
US5843921A (en) † 1994-03-15 1998-12-01 Childrens Hospital Of Los Angeles Therapeutic food composition and method to diminish blood sugar fluctuations
US5605893A (en) * 1994-03-15 1997-02-25 Children's Hospital Of Los Angeles Method of using a therapeutic food composition to diminish blood sugar fluctuations in diabetic patients
US5576048A (en) * 1995-06-07 1996-11-19 American Maize-Products Company Foodstuffs containing a waxy waxy amylose extender starch
JP2790610B2 (ja) * 1994-07-21 1998-08-27 ホクレン農業協同組合連合会 α−グルコシダーゼ阻害剤、それを含む糖組成物、甘味料、食品、及び飼料
JPH09172961A (ja) * 1995-12-22 1997-07-08 Oyama Nyugyo Nogyo Kyodo Kumiai ファットスプレッド様の発酵乳
JPH11130696A (ja) * 1997-08-27 1999-05-18 Takeda Chem Ind Ltd 経口徐放性製剤
US6238708B1 (en) * 1999-02-23 2001-05-29 The Iams Company Composition and process for controlling glucose metabolism in companion animals by dietary starch
DE19911001C2 (de) * 1999-03-12 2002-06-20 Aventis Cropscience Gmbh Verfahren zur Herstellung resistenter Stärke, resistente Stärke und deren Verwendung
FR2791686A1 (fr) * 1999-03-30 2000-10-06 Ulice Produits issus d'un ble a tres haute teneur en amylopectine et ses applications.
US6733815B2 (en) * 1999-04-16 2004-05-11 Cargill, Incorporated Food ingredient containing wheat gluten, soy grits and soy flour
JP3113873B1 (ja) * 1999-11-09 2000-12-04 株式会社日麺 ゆで麺及びその製造法
AUPQ673300A0 (en) * 2000-04-06 2000-05-04 Penford Australia Limited Starch sub-types and lipid metabolism
JP2004512306A (ja) * 2000-10-25 2004-04-22 メットコン・メディシン・アクチボラゲット 血糖代謝異常の処置のための新規組成物および方法
US7081261B2 (en) † 2002-05-14 2006-07-25 National Starch And Chemical Investment Holding Corporation Resistant starch prepared by isoamylase debranching of low amylose starch
US6890571B2 (en) † 2002-05-14 2005-05-10 National Starch And Chemical Investment Holding Corporation Slowly digestible starch product
GB0325942D0 (en) † 2003-11-06 2003-12-10 Glycologic Ltd Compositions and uses thereof
US20060025381A1 (en) † 2004-07-29 2006-02-02 National Starch And Chemical Investment Holding Company Use of a chemically modified starch product

Also Published As

Publication number Publication date
HRP20140660T4 (hr) 2018-08-10
NZ546987A (en) 2009-09-25
CY1115306T1 (el) 2017-01-04
AU2004287263A1 (en) 2005-05-19
HRP20140660T1 (en) 2014-10-10
CA2544965A1 (en) 2005-05-19
WO2005044284A1 (en) 2005-05-19
JP2007510704A (ja) 2007-04-26
DK1680134T4 (en) 2018-04-23
GB0325942D0 (en) 2003-12-10
CN1901922B (zh) 2011-10-26
EP1680134B1 (en) 2014-04-30
HK1097754A1 (en) 2007-07-06
CA2544965C (en) 2013-10-29
CN1901922A (zh) 2007-01-24
PT1680134E (pt) 2014-07-16
ES2478565T5 (es) 2018-04-17
SI1680134T1 (sl) 2014-09-30
PL1680134T5 (pl) 2018-06-29
AU2004287263B2 (en) 2011-01-27
US20070077277A1 (en) 2007-04-05
EP1680134A1 (en) 2006-07-19
DK1680134T3 (da) 2014-07-14
SI1680134T2 (en) 2018-04-30
JP5248776B2 (ja) 2013-07-31
US8507462B2 (en) 2013-08-13
EP1680134B2 (en) 2018-03-07
PL1680134T3 (pl) 2014-10-31

Similar Documents

Publication Publication Date Title
ES2532481T3 (es) Agente anti-obesidad y alimento anti-obesidad
ES2505258T3 (es) Método para la esterilización de productos alimentarios
ES2547222T3 (es) Producto cárnico transformado o producto de pasta de pescado y procedimiento para su producción
AR028512A1 (es) Composiciones antimicrobianas acidas para el tratamiento de alimentos y superficies que contactan alimentos y metodos para la utilizacion de estas
HK1086169A1 (en) Use of diphenylmethane derivatives as tyrosinase inhibitors
AR018924A1 (es) Composicion para la prevencion y/o tratamiento de osteoporosis y alteraciones debidas al sindrome de menopausia
DE60109589D1 (de) Pharmazeutische zusammensetzung zur behandlung von akutem schmerz, chronischem schmerz und/oder neuropathischem schmerz und migräne
ES2154336T3 (es) Producto para el cuidado de la piel.
ECSP105739A (es) Anticuerpos de neutralización contra gdf-8
AR028296A1 (es) Metodos sinergisticos y composiciones para el tratamiento del cancer
AR020345A1 (es) Pirazol-carboxanilidas, procedimiento para su obtencion, composiciones, empleo de dichos compuestos y procedimiento para la lucha contra microorganismos indeseables, y procedimiento para la obtencion de dichas composiciones.
AR054939A1 (es) Metodos para aplicar formulaciones antimicrobianas sobre alimentos
ES2130868T3 (es) Utilizacion de un extracto de al menos una iridacea en el tratamiento de las arrugas.
GEP20063818B (en) Orodispersible pharmaceutical composition comprising agomelatine
BR0212298A (pt) Composição farmacêutica compreendendo gabapentina ou um análogo da mesma e (alfa)-aminoamida e seu uso analgésico
BR0316442A (pt) Composição
UY26834A1 (es) Lípidos de la dieta para mejorar la piel y el pelaje de mascotas
ES2478565T3 (es) Composiciones y sus usos
JP2005511619A5 (es)
ITMI20031396A1 (it) Composizione per uso farmaceutico o dietetico o cosmetico dotata di attivita' antiossidante.
ES2172171T3 (es) Medicamento, que contiene yohimbina y arginina, para el tratamiento de disfunciones erectiles.
AR031505A1 (es) Un producto de cereal y/o legumbre y el procedimiento para prepararlo
CL2004001421A1 (es) Composicion farmaceutica que comprende un compuesto derivado de 1,4-dipiperidin-4-il-piperazina; y su uso para la prevencion y/o tratamiento del dolor.
CL2003001692A1 (es) Uso de n-(3-metoxi-5-metilpirazin-2-il)-2-(4-[1,3,4-oxadiazol-2-il]fenil)piridina-3-sulfonamida en la elaboracion de un medicamento para el tratamiento del cancer en un animal de sangre caliente.
AR029451A1 (es) Una composicion para su uso en la terapia del cancer de mamas en seres humanos y un producto para su uso en dicha terapia